Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents
- PMID: 16846596
- DOI: 10.1016/j.cbi.2006.05.012
Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents
Abstract
Nutritional intervention with specific fatty acids depresses tumor growth and enhances tumor responsiveness to chemotherapy. Supplementation of tumors with long chained omega-3 polyunsaturated fatty acids results in enrichment of tumor phospholipid fractions with omega-3 fatty acids resulting in an altered membrane composition and function. Tumors enriched with long chained omega-3 polyunsaturated fatty acids possess membranes with increased fluidity, an elevated unsaturation index, enhanced transport capabilities that results in accumulation of selective anti-cancer agents, increased activity of selected drug activating enzymes, and alteration of signaling pathways important for cancer progression. These nutritionally induced changes in tumor fatty acid composition result in increased sensitivity to chemotherapy, especially in tumor lines that are resistant to chemotherapy and cause specific enhancement of cytotoxicity to tumor cells and protection of normal cells. Pre-disposing tumors to increased chemo-sensitivity through nutritional intervention with specific fatty acids has the potential to improve patient response to chemotherapy with fewer untoward side effects if these pre-clinical findings carry over into a clinical setting.
Similar articles
-
The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy.J Nutr Biochem. 2008 Dec;19(12):787-96. doi: 10.1016/j.jnutbio.2008.02.003. Epub 2008 Jul 7. J Nutr Biochem. 2008. PMID: 18602809 Review.
-
The effects of lipids on the immune response of patients with cancer.J Nutr Health Aging. 2000;4(3):172-5. J Nutr Health Aging. 2000. PMID: 10936906 Review.
-
Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.Free Radic Biol Med. 2005 Sep 15;39(6):742-51. doi: 10.1016/j.freeradbiomed.2005.04.023. Free Radic Biol Med. 2005. PMID: 16109304
-
Omega-3 fatty acids: investigations from cytokine regulation to pancreatic cancer gene suppression.Arch Surg. 2010 Jun;145(6):515-20. doi: 10.1001/archsurg.2010.91. Arch Surg. 2010. PMID: 20566969 Review.
-
Omega-3 fatty acids in cancer.Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):156-61. doi: 10.1097/MCO.0b013e32835d2d99. Curr Opin Clin Nutr Metab Care. 2013. PMID: 23299701 Review.
Cited by
-
Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Mediators Inflamm. 2014;2014:848632. doi: 10.1155/2014/848632. Epub 2014 Apr 30. Mediators Inflamm. 2014. PMID: 24876678 Free PMC article. Review.
-
DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells.Oncotarget. 2019 Oct 15;10(57):5983-5992. doi: 10.18632/oncotarget.27236. eCollection 2019 Oct 15. Oncotarget. 2019. PMID: 31666929 Free PMC article.
-
Shrimp lipids: a source of cancer chemopreventive compounds.Mar Drugs. 2013 Oct 16;11(10):3926-50. doi: 10.3390/md11103926. Mar Drugs. 2013. PMID: 24135910 Free PMC article. Review.
-
Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth.Prostaglandins Leukot Essent Fatty Acids. 2014 Apr;90(4):105-115. doi: 10.1016/j.plefa.2013.12.001. Epub 2013 Dec 11. Prostaglandins Leukot Essent Fatty Acids. 2014. PMID: 24374147 Free PMC article.
-
Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview.Springerplus. 2016 May 10;5:585. doi: 10.1186/s40064-016-2216-3. eCollection 2016. Springerplus. 2016. PMID: 27247882 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources